-
In Seoul square of protest and history, BTS fans welcome grand comeback
-
Hong Kong panel hears safety measures failed on day of deadly fire
-
Trump threatens to destroy Iran's largest gas field
-
Doncic and James power Lakers over Rockets as win streak hits seven
-
Inter continue Serie A title hunt ahead of Italy's date with World Cup destiny
-
Strait of Hormuz blockage drives up Gulf food bills
-
Ahead of election, Danish city mirrors country's challenges
-
Wild possum shelters with plush toys in Australian airport shop
-
Iran missile fire kills 3 Palestinians in West Bank, foreign worker in Israel
-
Asian Games cruise ship and wooden huts will be 'unique experience'
-
Pacific nations fear fuel shortages as Middle East war sends oil prices soaring
-
World indoor athletics championships: five stand-out events
-
Crude prices surge, stocks sink as Iran warns of regional energy strikes
-
'No oil, no money': Orban brings Ukraine standoff to Brussels
-
Mideast energy shock rattles eurozone rate-setters
-
Scotland's Laidlaw extends tenure as Hurricanes coach
-
Messi scores 900th career goal but Miami crash out
-
Japan coach says Australia 'massive favourites' in Asian Cup final
-
Iran targets Gulf energy sites after gas field strike
-
Director plans to put Val Kilmer back on screen thanks to AI
-
Social media addiction trial jury deliberations continue
-
Messi scores 900th career goal in Inter Miami cup clash
-
Barcelona, Liverpool, Bayern and Atletico reach Champions League quarter-finals
-
Tudor impressed by 'improved' Spurs despite Champions League exit
-
PSG will not relish Liverpool reunion, says Slot
-
Kane says Bayern 'don't fear anyone' ahead of Real clash
-
Venezuelan leader sacks defense minister, a Maduro stalwart
-
Kane and Bayern swat aside Atalanta to set up Real clash
-
Thailand's new parliament set to elect Anutin as PM
-
Atletico survive Spurs scare to reach Champions League quarters
-
Liverpool thrash Galatasaray to reach Champions League quarters
-
Music popstar will.i.am meshes AI and 'micromobility'
-
US Fed Chair says 'no intention' of leaving board while probe ongoing
-
US stocks fall on latest oil price surge as Fed lifts inflation forecast
-
Iran targets Gulf energy sites after intel chief killed
-
Costa Rica closes Havana embassy, tells Cuba to withdraw diplomats
-
NY's New Museum returns contemporary to heart of Manhattan
-
Cesar Chavez, icon of US labor movement, accused of serial sex abuse: report
-
Barcelona demolish Newcastle 7-2 to reach Champions League quarters
-
US Fed raises inflation outlook over 'uncertain' Iran war impact
-
Trump nominee for Homeland Security chief grilled at fiery Senate hearing
-
First international aid convoy arrives in crisis-hit Cuba
-
Eight killed during Rio police operation, including drug kingpin
-
Iran suffers new blow as Israel kills intel chief
-
Slovakia curbs diesel sales, ups prices for foreigners
-
Oscar-winner Sean Penn meets troops in frontline Ukraine
-
Thousands rally in Istanbul to mark year since mayor's arrest
-
WNBA, players union agree 'transformative' labor deal: official
-
US Fed holds rates unchanged over 'uncertain' Iran war implications
-
Senegal govt calls for investigation into Cup of Nations decision
US court keeps abortion drug available -- for now
A US appeals court has blocked moves to ban a widely-used abortion pill -- but imposed tough restrictions on access, in the latest round of an intensifying battle over reproductive rights.
The ruling issued late Wednesday preserves access for now to mifepristone -- used for more than half of all abortions in the United States -- but a question mark remains over its long-term availability in a case likely to go all the way to Supreme Court.
The new order limits access to women in the first seven weeks of pregnancy, down from 10; it requires in-person visits to obtain the pill -- a requirement lifted in recent years; and it blocks the medication from being sent by mail.
Wednesday's 2-1 ruling by a federal appeals court in New Orleans, Louisiana, came after a Texas judge overturned the Food and Drug Administration's (FDA) two-decades old approval of the drug last Friday.
The appellate court said its ruling would hold until the case was heard in full -- likely by the Supreme Court.
The latest standoff over women's reproductive freedom in America comes almost a year after the conservative-dominated Supreme Court overturned the landmark Roe v. Wade ruling that had enshrined the constitutional right to abortion for half a century.
- 'Commitment to women' -
US President Joe Biden has branded the Texas ruling as "out of bounds," and his spokeswoman, Karine Jean-Pierre, said Thursday the administration would continue fighting it in court.
"We believe that the law is on our side, and we will prevail," she told reporters during the president's visit to Dublin, Ireland.
"I can reassure the American people that that is our commitment to women ... to make sure that women are able to make decisions for themselves about their own body," she added.
Democrats and activists warn the Texas ruling -- issued by a judge appointed by former Republican president Donald Trump -- moves the nation one step closer to a nationwide abortion ban sought by many conservatives.
Judge Matthew Kacsmaryk's ruling came after a coalition of anti-abortion groups sued to freeze the national distribution of mifepristone.
The Texas judge, in his decision, adopted language used by abortion opponents, referring to abortion providers as "abortionists" and saying the drug was used to "kill the unborn human."
Kacsmaryk said the two-drug regimen that includes mifepristone had resulted in "thousands of adverse events suffered by women and girls," including intense bleeding and psychological trauma.
But the FDA, researchers and the drugmaker say decades of experience have proven the medication to be safe and effective when used as indicated.
Polls repeatedly show a clear majority of Americans support continued access to safe abortion, even as conservative groups push to limit access the procedure -- or ban it outright.
The two New Orleans judges who voted to tighten restrictions on access, Kurt Engelhardt and Andrew Oldham, were also both appointed by Trump.
The third, Catharina Haynes, is an appointee of former president George W. Bush.
Shortly after the initial Texas decision, a judge in Washington state ruled in a separate case that access to mifepristone must be preserved. The dueling opinions, along with the appeals, mean the issue is almost certain to end up before the Supreme Court.
D.Schneider--BTB